Paola Pozzi
Director/Board Member at Fondazione per la Scuola della Compagnia di San Paolo
Profile
Paola Pozzi is associated with multiple firms and holds the position of Director in Fondazione per la Scuola della Compagnia di San Paolo, Chroma Medicine, Inc., and AAVantgarde Bio Srl.
She is also a Partner at Sofinnova Partners SAS since 2018.
Paola Pozzi active positions
Companies | Position | Start |
---|---|---|
Fondazione per la Scuola della Compagnia di San Paolo
Fondazione per la Scuola della Compagnia di San Paolo Investment Trusts/Mutual FundsMiscellaneous Fondazione per la Scuola della Compagnia di San Paolo aims to contribute to the effectiveness of the education system. Its activities are directed towards the development of school autonomy such as the promotion of scientific research as well as the collaboration with schools in didactic planning and the expansion of training activities. The company was founded on August 27, 1595 and is headquartered in Turin, Italy. | Director/Board Member | - |
Sofinnova Partners SAS
Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Private Equity Investor | 2018-09-30 |
AAVantgarde Bio Srl
AAVantgarde Bio Srl Miscellaneous Commercial ServicesCommercial Services AAVantgarde Bio Srl is an Italian company that provides scientific research and development services. The company is based in Milan, Italy. The company was founded by Alberto Auricchio. Natalia Misciattelli has been the CEO of the company since 2022. | Director/Board Member | - |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Sofinnova Partners SAS
Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Finance |
Fondazione per la Scuola della Compagnia di San Paolo
Fondazione per la Scuola della Compagnia di San Paolo Investment Trusts/Mutual FundsMiscellaneous Fondazione per la Scuola della Compagnia di San Paolo aims to contribute to the effectiveness of the education system. Its activities are directed towards the development of school autonomy such as the promotion of scientific research as well as the collaboration with schools in didactic planning and the expansion of training activities. The company was founded on August 27, 1595 and is headquartered in Turin, Italy. | Miscellaneous |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | Health Technology |
AAVantgarde Bio Srl
AAVantgarde Bio Srl Miscellaneous Commercial ServicesCommercial Services AAVantgarde Bio Srl is an Italian company that provides scientific research and development services. The company is based in Milan, Italy. The company was founded by Alberto Auricchio. Natalia Misciattelli has been the CEO of the company since 2022. | Commercial Services |
- Stock Market
- Insiders
- Paola Pozzi